Retain CHD7, an Epigenetic Regulator, in the Nucleus to Combat Breast Cancer Metastasis
ISEF · 2017 Cellular and Molecular Biology Third Award
Overview
Metastasis accounts for ~90% of deaths from breast cancer (BC). This study aims to address the fundamental question of how cancer cells in the primary breast tumor become metastatic. CHD7 is an ATP-dependent nucleosome remodeling factor which acts in the nucleus to epigenetically regulate gene expression. I found that CHD7 is primarily localized in the cytoplasm of highly metastatic BC cell lines, where it is unable to function. I hypothesize that exporting CHD7 into the cytoplasm plays a critical role in the metastasis of BC cells. First, I examined the cellular localization of CHD7 in human invasive BC tumors. In normal breast duct epithelial cells, CHD7 was exclusively localized in the nucleus; whereas in epithelial cells of BC tumors, a large portion of CHD7 was localized in the cytoplasm. This result strongly supports the clinical relevance of the subcellular localization of CHD7 in metastatic BC cells. Next, through reporter analyses, I identified a nuclear export signal (NES) sequence of CHD7 in MDA-MB-231 metastatic cells. I applied CRISPR/Cas9 to mutate the NES sequence of endogenous CHD7 and showed that mutating the NES sequence led to accumulation of CHD7 in the nucleus of MDA-MB-231 cells and significantly reduced their invasiveness. Finally, I revealed that CHD7, when present in the nucleus, upregulates CDH1/E-cadherin transcription through reducing the nucleosome density of its promoter. CDH1/E-cadherin is well-known to repress BC cell invasiveness. Our data collectively suggest that retaining CHD7 in the nucleus may serve as an effective therapeutic strategy to inhibit BC metastasis.
Awards (1)
- Third Award of $1,000 $1,000
Competition history
- ISEF 2017
Resources
Related projects
ISEF · 2016
An Epigenetic Factor, CHD7, Inhibits Migration of Metastatic Breast Cancer Cells
ISEF · 2014
A Novel Approach for Metastatic Breast Cancer Therapy: Pharmacological Inhibition of EZH2 Histone Methyl Transferase Activity Suppresses Cancer Stem Cells and Induces Epithelial Phenotype
ISEF · 2024
Targeting of Epichaperome Downregulates HCFC1 Mediated Transcription of Oncogenes: Implications in Breast Cancer Therapy
ISEF · 2026
Shaped by Signals: Leveraging Breast Cancer Nuclear Morphology to Elucidate Regulatory Pathways as Therapeutic Targets
ISEF · 2015
Sorting Nexin 27, a Novel Target Gene to Prevent Tumor Metastasis in Highly Aggressive Breast Cancer Cells
ISEF · 2026
CNOT9/DBN1 Actin Dysregulation in QNBC Metastasis & Heterogeneity
ISEF · 2023
Cure of Breast Cancer-Year 6: Novel Approaches in the Therapy of Metastatic Breast Cancer Using Clinical Databases and 3D Organoid Model
ISEF · 2020
Investigating Amalgamations of NURF Knockdown and Chemotherapies through Metabolic Deviations in Tumor Cells
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair